ERA4TB launched a series of webinars aimed at exploring key topics in relation to tuberculosis and antimicrobial research and development from clinical, regulatory and HTA perspectives. With the title “Challenges of tuberculosis (TB) drug development and access – clinical, regulatory and HTA perspectives”, the first webinar was held on 24th November 2022, 11.00-12.15 GMT coinciding with World Antimicrobial Awareness […]

About fifteen people attended the kick-off meeting of the Scientific Interest Group (SIG) on machine learning (ML). First, all attendees introduced themselves and outlined their interest in ML. Frederik Deroose, SIG Chairman, Connecting Pharma (ex-Asclepia Outsourcing Solutions) and Philip Gribbon, SIG Leader, Fraunhofer ITMP introduced the ML Scientific Interest Group (SIG) and its charter. Daniel […]

About fifteen people attended the kick-off meeting of the Scientific Interest Group (SIG) on animal models. First, all attendees introduced themselves and outlined which models they currently use in their project. Frederik Deroose, SIG Chairman, Connecting Pharma (ex-Asclepia Outsourcing Solutions), SIG Chairman and Carina Vingsbo Lundberg, SIG Leader, Statens Serum Institut introduced the Animal Models […]